Following ‘CRISPR Babies’ Scandal, Senators Call for International Gene Editing Guidelines
By Andrew Joseph,
STAT+
| 07. 15. 2019
A bipartisan trio of senators has introduced a resolution underscoring their opposition to the experiments last year in China that led to the birth of the world’s first genome-edited babies.
A bipartisan trio of senators on Monday introduced a resolution underscoring their opposition to the experiments last year in China that led to the birth of the world’s first genome-edited babies.
The resolution from Sens. Dianne Feinstein (D-Calif.), Marco Rubio (R-Fla.), and Jack Reed (D-R.I.) also reiterated support for international groups working to produce guidelines for the clinical use of germline editing — meaning changes to the DNA in sperm, eggs, or early embryos that would be passed down to future generations.
If passed, the resolution would not change U.S. law; editing embryos with the purpose of creating children is already illegal in the United States. But the action by the senators stands out, since some members of Congress have recently expressed some openness to lifting the ban on editing embryos used to start pregnancies. Scientists in other countries have also announced plans to continue pursuing such experiments, and some scientific and patient advocacy groups have emphasized how germline editing, once the technology improves, could stave off cases of genetic disease.
“Gene editing is a powerful technology that... see more
Related Articles
"Black-footed Ferret Kits" by USFWS Mountain Prairie
is licensed under CC BY 2.0
The New York Times published on February 18 an enthusiastic article about a black-footed ferret, hailing it as “the first of any native, endangered animal species in North America to be cloned.”
As we have been documenting for many years (see below), grand claims for animal cloning go back to the birth of the first cloned sheep, in 1996. The New York Times was so excited by...
By Matthew Hutson, The New Yorker | 02.15.2021
In computer science, the main outlets for peer-reviewed research are not journals but conferences, where accepted papers are presented in the form of talks or posters. In June, 2019, at a large artificial-intelligence conference in Long Beach, California, called Computer...
By Adam Feuerstein, STAT | 02.16.2021
Bluebird Bio said Tuesday that it has suspended clinical trials involving its gene therapy for sickle cell disease after receiving reports that two patients treated with the one-time therapy were diagnosed with cancer.
The trials were placed on “temporary suspension”...
By Jocelyn Kaiser, Science | 02.16.2021
A company has stopped its clinical studies of a promising gene therapy for the blood disorder sickle cell disease after two people who participated developed leukemia-like cancer. Bluebird bio is now investigating whether a virus it uses to deliver a...
